Navigation Links
Michigan Life Science Network to Form Two New Virtual Companies
Date:10/9/2007

selves, the process will quickly create unity, new value, and knowledge of each other.

At the exhibit, a very large graphical organization chart will represent each of the two companies. The chart is intended to be very visual and tactile to contribute to the overall understanding of the project. The goal will be to see how quickly all the state's life science companies can fill in who has each kind of expertise in the blank boxes. Each box is the size of a business card. Attendees at the Expo and afterward on an on-going basis will be invited to add their cards under the function they can provide in making up the whole company.

The Virtual Companies Project is sponsored by the members of the Network themselves and the financial and professional support of Kreis, Enderle, Callander & Hudgins, PC, TCF Bank, Grubb & Ellis|Paramount Commerce, and Comerica Bank.

"The creation of these two Virtual Companies is just the start for what needs to be done to stimulate life science business in Michigan. The Michigan Life Science Network is developing many of the next step initiatives to bring new business into these individual companies by marketing the larger virtual organization," said Debiak.

The Virtual Company Launch Party will be held October 16 from 7 to 10 p.m. at the Tavern on the Square in Downtown Lansing. All are welcome.

For more information about the Michigan Life Science Network or the launch of the Virtual Companies, please contact:

Michael Debiak

President

Michigan Life Science Network

mike@milifesciencenetwork.com

269-353-1575

Offices in Ann Arbor, Kalamazoo, and TechTown Detroit

The Michigan Life Science Network, LLC was founded in early 2007 as a private enterprise business cooperative to stimulate new, better and more business for all life science businesses in Michigan. Using advanced communications, marketing/sales technology and tec
'/>"/>

SOURCE The Michigan Life Science Network
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Venture Investors to open Michigan office
2. University of Michigan plans major stem cell research center
3. CPM contributes marketing program to Michigan hospital
4. For Now, Michigan Can Celebrate $150 Million Entrepreneurial VC Fund
5. Michigan Growth Capital Symposium includes Wisconsin Tech Companies
6. Advantages of Roche Applied Science amplification products
7. Tools for Proteomic Science II
8. Exploiting the Life Science Data Explosion to Speed New Drug Discovery
9. Food science: increasing crop yields
10. Automation of the Eppendorf Perfectprep BAC 96 DNA Kit on the Caliper Life Sciences Sciclone ALH 3000
11. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
(Date:10/20/2014)... , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Horovitz , Ph.D., from its board of directors effective on ... August 2003, and served as its chairman from June 2006 ... the Nominating and Corporate Governance and Audit Committees of the ... than a decade of dedicated service to GenVec, and its ...
(Date:10/20/2014)... Virginia (PRWEB) October 20, 2014 ... NDA Partners LLC, announced today that Ellen Teplitzky, ... legal support for the pharmaceutical industry, has joined ... manager of its legal services practice. NDA ... and expert witness and testimony, to top law ...
(Date:10/19/2014)... 20, 2014 OCTOBER 20-22, ... (ABIM). ABIM will take place at ... about ABIM 2014 is now available at ... representing companies and organizations from all over ... information on the latest products and developments ...
Breaking Biology Technology:Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2
... MATK ) announced that it intends to release the results ... 2008, at approximately 4:00 p.m. Eastern Time (ET). Following the ... to discuss these results with investors. All interested parties may ... site at http://investors.martek.com . , , ...
... -- Tianyin,Pharmaceutical, Co., Inc., (NYSE EuroNext: TPI), a ... based in Chengdu, China,today announced the implementation of ... distributors and hospital clients into three classes in ... The new ...
... MD, FACS, as Principal Investigator , , ... Inc. (Nasdaq: DCTH ) announced today that ... Medical Center (UPMC), has joined Delcath,s Phase III clinical ... metastatic melanoma in the liver. James Pingpank, MD, FACS, ...
Cached Biology Technology:Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 2Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 3Delcath Adds University of Pittsburgh Medical Center to Phase III Trial 2Delcath Adds University of Pittsburgh Medical Center to Phase III Trial 3Delcath Adds University of Pittsburgh Medical Center to Phase III Trial 4
(Date:10/15/2014)... NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ("NXT-ID" or ... commerce market releases photos and video of the recent opening bell ... th . Gino Pereira , CEO of ... Mr. Chad A. Verdi rang the bell.  ... and employees "for their work and dedication in bringing the world,s ...
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to inhibit ... development of skin cancers by turning on an enzyme ... cells. , Previously considered protective, SIRT6 is part of ... regulate genomic stability and prevent some of the genetic ... which can lead to cancer. This study, in the ...
(Date:10/14/2014)... a new kind of stem cell that can become either ... vessels, according to a study published today in the journal ... cell type contradicts current theory on how organs arise from ... origins of, and future treatment for, liver cancer., Thanks to ... complex being made up of more than 200 cell types. ...
Breaking Biology News(10 mins):Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 2Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 3
... November 2, 2010 CONRAD, leaders in reproductive health ... from the US Agency for International Development (USAID). The ... are contraceptive and also prevent HIV and STI infections. ... of tenofovir gel, conducted by the Centre for Programme Research ...
... Please credit the journal or the American Chemical Society as ... For the first time in the United States, researchers ... Bisphenol A (BPA) in fresh and canned food as well ... limited sample, however, were almost 1,000 times lower than the ...
... knows better "The Promise of Human Genetics" than the man ... D.C. on Wednesday: this year,s Gruber Genetics Prize recipient Prof. ... "grow" genes in yeast, thus allowing scientists to create and ... cells inherit information. It is Fink whose "transforming" technique effectively ...
Cached Biology News:USAID awards $5 million to CONRAD 2Fink receives Gruber Genetics Prize, lectures at American Society of Human Genetics annual meeting 2
...
Template and primers for preparation of internal control spots...
Biotin-OSu is used to label proteins, immunological agents, DNA and synthetic oligonucleotides. Biotin labeling is detected through enzymatically labeled avidin or streptavidin proteins that conforma...
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Biology Products: